Given the risk model’s proficiency in forecasting the survival rates of GBM patients, we subsequently investigated the correlation between genes associated with the risk model (SOD3, SPAG4, FREM3, and SPP1) and the immune microenvironment. The gene discussed is SPP1; the disease is glioblastoma.